SUCAMPO PHARMACEUTICALS, INC. Research and Development Expense
SUCAMPO PHARMACEUTICALS, INC. reported Research and Development Expense of $10.13 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-11-01
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2017-09-30 was $10.13M, a 1.57% increase year-over-year.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2017-06-30 was $19.10M, a 74.69% increase year-over-year.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2017-03-31 was $10.33M, a 29.57% decline year-over-year.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2016-12-31 was $11.04M, a 2.74% decline year-over-year.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for fiscal 2016 was $46.62M, a 38.61% increase from fiscal 2015.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for fiscal 2015 was $33.63M, a 63.53% increase from fiscal 2014.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for fiscal 2014 was $20.57M, a 4.45% decline from fiscal 2013.
- SUCAMPO PHARMACEUTICALS, INC. research and development expense for fiscal 2013 was $21.52M, a 1.09% increase from fiscal 2012.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-09-30 | $10.13M 10-Q · filed 2017-11-01 | $29.23M derived: sum of 2 quarters · filed 2017-11-01 | $39.56M 10-Q · filed 2017-11-01 | $50.60M derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | $19.10M 10-Q · filed 2017-08-02 | $29.43M 10-Q · filed 2017-08-02 | $40.47M derived: sum of 3 quarters · filed 2017-08-02 | $50.44M derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-03-31 | $10.33M 10-Q · filed 2017-05-03 | $21.37M derived: sum of 2 quarters · filed 2017-05-03 | $31.34M derived: sum of 3 quarters · filed 2017-11-01 | $42.28M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-12-31 | $11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $21.01M derived: sum of 2 quarters · filed 2017-11-01 | $31.94M derived: sum of 3 quarters · filed 2017-11-01 | $46.62M 10-K · filed 2017-03-08 |
| 2016-09-30 | $9.98M 10-Q · filed 2017-11-01 | $20.91M derived: sum of 2 quarters · filed 2017-11-01 | $35.58M 10-Q · filed 2017-11-01 | $46.93M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | $10.93M 10-Q · filed 2017-08-02 | $25.60M 10-Q · filed 2017-08-02 | $36.95M derived: sum of 3 quarters · filed 2017-08-02 | $45.32M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | $14.67M 10-Q · filed 2017-05-03 | $26.02M derived: sum of 2 quarters · filed 2017-05-03 | $34.38M derived: sum of 3 quarters · filed 2017-05-03 | $41.51M derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | $11.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $19.71M derived: sum of 2 quarters · filed 2017-03-08 | $26.84M derived: sum of 3 quarters · filed 2017-03-08 | $33.63M 10-K · filed 2017-03-08 |
| 2015-09-30 | $8.37M 10-Q · filed 2016-11-09 | $15.49M derived: sum of 2 quarters · filed 2016-11-09 | $22.29M 10-Q · filed 2016-11-09 | $28.17M derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-06-30 | $7.12M 10-Q · filed 2016-08-03 | $13.92M 10-Q · filed 2016-08-03 | $19.80M derived: sum of 3 quarters · filed 2017-03-08 | $25.10M derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-03-31 | $6.79M 10-Q · filed 2016-05-05 | $12.68M derived: sum of 2 quarters · filed 2017-03-08 | $17.97M derived: sum of 3 quarters · filed 2017-03-08 | $22.22M derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $11.18M derived: sum of 2 quarters · filed 2017-03-08 | $15.43M derived: sum of 3 quarters · filed 2017-03-08 | $20.57M 10-K · filed 2017-03-08 |
| 2014-09-30 | $5.30M 10-Q · filed 2015-11-04 | $9.55M derived: sum of 2 quarters · filed 2015-11-04 | $14.68M 10-Q · filed 2015-11-04 | $21.68M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-06-30 | $4.25M 10-Q · filed 2015-08-05 | $9.39M 10-Q · filed 2015-08-05 | $16.38M derived: sum of 3 quarters · filed 2016-03-16 | $20.86M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-03-31 | $5.13M 10-Q · filed 2015-05-06 | $12.13M derived: sum of 2 quarters · filed 2016-03-16 | $16.61M derived: sum of 3 quarters · filed 2016-03-16 | $21.03M derived: sum of 4 quarters · filed 2016-03-16 |
| 2013-12-31 | $7.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-03-16 | $11.47M derived: sum of 2 quarters · filed 2016-03-16 | $15.89M derived: sum of 3 quarters · filed 2016-03-16 | $21.52M 10-K/A · filed 2016-03-16 |
| 2013-09-30 | $4.47M 10-Q · filed 2014-11-07 | $8.90M derived: sum of 2 quarters · filed 2014-11-07 | $14.53M 10-Q · filed 2014-11-07 | $21.62M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | $4.42M 10-Q · filed 2014-08-06 | $10.05M 10-Q · filed 2014-08-06 | $17.14M derived: sum of 3 quarters · filed 2015-03-09 | $22.76M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $5.63M 10-Q · filed 2014-05-09 | $12.72M derived: sum of 2 quarters · filed 2015-03-09 | $18.33M derived: sum of 3 quarters · filed 2015-03-09 | $23.57M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $12.71M derived: sum of 2 quarters · filed 2015-03-09 | $17.94M derived: sum of 3 quarters · filed 2015-03-09 | $21.29M 10-K · filed 2015-03-09 |
| 2012-09-30 | $5.62M 10-Q · filed 2013-11-08 | $10.85M derived: sum of 2 quarters · filed 2013-11-08 | $14.20M 10-Q · filed 2013-11-08 | $21.86M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $5.24M 10-Q · filed 2013-08-09 | $8.59M 10-Q · filed 2013-08-09 | $16.25M derived: sum of 3 quarters · filed 2014-03-12 | $24.97M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $3.35M 10-Q · filed 2013-05-10 | $11.01M derived: sum of 2 quarters · filed 2014-03-12 | $19.74M derived: sum of 3 quarters · filed 2014-03-12 | $27.63M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $16.38M derived: sum of 2 quarters · filed 2014-03-12 | $24.28M derived: sum of 3 quarters · filed 2014-03-12 | $33.50M 10-K · filed 2014-03-12 |
| 2011-09-30 | $8.72M 10-Q · filed 2012-11-09 | $16.62M derived: sum of 2 quarters · filed 2012-11-09 | $25.84M 10-Q · filed 2012-11-09 | $33.31M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $7.89M 10-Q · filed 2012-08-09 | $17.11M 10-Q · filed 2012-08-09 | $24.59M derived: sum of 3 quarters · filed 2013-03-18 | $30.85M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $9.22M 10-Q · filed 2012-05-10 | $16.69M derived: sum of 2 quarters · filed 2013-03-18 | $22.95M derived: sum of 3 quarters · filed 2013-03-18 | $27.81M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $13.73M derived: sum of 2 quarters · filed 2013-03-18 | $18.59M derived: sum of 3 quarters · filed 2013-03-18 | $23.95M 10-K · filed 2013-03-18 |
| 2010-09-30 | $6.26M 10-Q · filed 2011-11-09 | $11.12M derived: sum of 2 quarters · filed 2011-11-09 | $16.48M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $4.86M 10-Q · filed 2011-08-05 | $10.22M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $32.91M 10-K · filed 2012-03-15 |